| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/07/2002 | WO2002017891A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 03/07/2002 | WO2002017878A1 Lung surfactant compositions with dynamic swelling behaviour |
| 03/07/2002 | WO2002017856A2 Compositions and methods relating to hypertension |
| 03/07/2002 | WO2002017852A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 03/07/2002 | WO2002017713A1 Collagen/polysaccharide bilayer matrix |
| 03/07/2002 | WO2001094420B1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 03/07/2002 | WO2001093911A3 Macromolecular drug complexes and compositions containing the same |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001088092A3 Methods and materials relating to stem cell factor-like (scf-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001087329A8 Liquid pharmaceutical composition containing an erythropoietin derivate |
| 03/07/2002 | WO2001085777A3 Therapeutic pore-forming peptides |
| 03/07/2002 | WO2001083695A3 Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 03/07/2002 | WO2001080811A3 Mmp-2 propeptide for use as antiangiogenic or antitumor agent |
| 03/07/2002 | WO2001079431A3 A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide |
| 03/07/2002 | WO2001072330A3 Method for immunostimulation using binding agents for the fc rec eptor of immunoglobulin a and for cancer cells or infections antigen |
| 03/07/2002 | WO2001068856A3 Human transcription factor-like protein and nucleic acids encoding same |
| 03/07/2002 | WO2001068840A3 REGULATION OF HUMAN DIAZEPAM BINDING INHIBITOR/ACYL-CoA-LIKE PROTEIN |
| 03/07/2002 | WO2001068122A3 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity 'mia' |
| 03/07/2002 | WO2001068112A3 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility |
| 03/07/2002 | WO2001066738A3 Nucleic acids, encoding human crsp1 and uses thereof |
| 03/07/2002 | WO2001064887A3 32705, 23224, 27423, 32700, 32712, novel human g-proteins |
| 03/07/2002 | WO2001064872A3 Gene 2465: methods and compositions for the diagnosis and treatment of cardiovascular, hepatic and bone disease |
| 03/07/2002 | WO2001062936A3 Bunyaviridal reaper proteins and uses therefor |
| 03/07/2002 | WO2001062788A3 Corneodesmosin based test and model for inflammatory disease |
| 03/07/2002 | WO2001060983A3 Treatment for bone disorders |
| 03/07/2002 | WO2001060865A8 Novel proteins and nucleic acids encoding same |
| 03/07/2002 | WO2001060414A3 Genetic modification of the lung as a portal for gene delivery |
| 03/07/2002 | WO2001059130A3 Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/07/2002 | WO2001059114A3 Tumor suppressor gene, p47ing3 |
| 03/07/2002 | WO2001059078A3 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 03/07/2002 | WO2001058949A3 Heterologous polypeptide of the tnf family |
| 03/07/2002 | WO2001058471A3 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 03/07/2002 | WO2001057233A3 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001055335A3 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides |
| 03/07/2002 | WO2001055331A3 thdF |
| 03/07/2002 | WO2001055219A3 scsCNTFR/NNT-1 FUSION PROTEIN |
| 03/07/2002 | WO2001055177A3 Methods to identify ctl epitopes of hiv |
| 03/07/2002 | WO2001055174A3 Universal procedure for refolding recombinant proteins |
| 03/07/2002 | WO2001053493A3 Human kinase protein and polynucleotides encoding the same |
| 03/07/2002 | WO2001053468A3 Lipid metabolism enzymes and polynucleotides encoding them |
| 03/07/2002 | WO2001051636A3 Secreted proteins |
| 03/07/2002 | WO2001051624A3 Carboxypeptidase b free of animal products and contaminating enyzme activity |
| 03/07/2002 | WO2001051093A3 METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS |
| 03/07/2002 | WO2001046405A3 Modulation of pax-2 for controlled apoptosis or survival of cells |
| 03/07/2002 | WO2001046231A3 Polynucleotides and polypeptides encoded thereby |
| 03/07/2002 | WO2001044271A3 Daptomycin analogs and their use as antibacterial agents |
| 03/07/2002 | WO2001043761A3 Methods for treating and preventing damage to mucosal tissue |
| 03/07/2002 | WO2001042285A3 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 03/07/2002 | WO2001042280A3 Short peptides from the b4 and b5 regions of protein kinases which selectively modulate protein activity |
| 03/07/2002 | WO2001040474A3 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/07/2002 | WO2001036039A3 Iontophoretic transdermal delivery of peptides |
| 03/07/2002 | WO2001034774A3 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 03/07/2002 | WO2001034645A3 Mutated il-13 molecules and their uses |
| 03/07/2002 | WO2001032888A3 Human transferase molecules |
| 03/07/2002 | WO2001032874A3 Polypeptides and nucleic acids encoding same |
| 03/07/2002 | WO2001032197A3 Methods of using lp8, a pdgf-related protein, to treat musculoskeletal disorders |
| 03/07/2002 | WO2001031008A3 Human and rat fgf-20 genes and gene expression products |
| 03/07/2002 | WO2001031006A3 Serum amyloid a isoform from colostrum |
| 03/07/2002 | WO2001029220A3 Mage-a12 antigenic peptides and uses thereof |
| 03/07/2002 | WO2001028591A3 Injection vehicle for polymer-based formulations |
| 03/07/2002 | WO2001024831A3 Polymer stabilized neuropeptides |
| 03/07/2002 | WO2001021647A3 Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
| 03/07/2002 | WO2001021163A3 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/07/2002 | WO2001019870A3 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/07/2002 | WO2001016324A3 Methods and compositions of a novel serine protease inhibitor |
| 03/07/2002 | WO2001011049A3 Methods and compositions concerning canine interleukin 5 |
| 03/07/2002 | WO2000073344A9 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 03/07/2002 | WO2000071571A8 Fap-activated anti-tumor compounds |
| 03/07/2002 | WO2000056352A3 Reagents and methods useful for detecting diseases of the prostate |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028925 Hsv viral vector |
| 03/07/2002 | US20020028919 Viricides, anticancer or antitumor agents |
| 03/07/2002 | US20020028915 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/07/2002 | US20020028914 Chimeric toxins for targeted therapy |
| 03/07/2002 | US20020028913 Conformationally stabilized cell adhesion peptides |
| 03/07/2002 | US20020028912 Polyethylene glycol derivative modifying granulocyte colony stimulating factor activity |
| 03/07/2002 | US20020028838 E.g., 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7 hexahydro-pyrazolo-(4,3-c)pyridin-5-yl)-1-(R)-benzyloxymethyl- 2-oxo-ethyl)-isobutyramide; mobility impairments, e.g. identified by balance and gait, in the elderly |
| 03/07/2002 | US20020028798 Analgesics, antiinflammatory agents; mixture containing enzyme inhibitor |
| 03/07/2002 | US20020028791 Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines |
| 03/07/2002 | US20020028786 Methods and compositions for enhancing cellular function through protection of tissue components |
| 03/07/2002 | US20020028783 Method of stimulating prosaposin receptor activity |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | US20020028773 Genetic engineering |
| 03/07/2002 | US20020028772 Modulation of metabolism |
| 03/07/2002 | US20020028771 Sulfonylation core antibiotic |
| 03/07/2002 | US20020028770 Bactericides |
| 03/07/2002 | US20020028768 Antilipemic agents and hyperglycemic agents |
| 03/07/2002 | US20020028766 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/07/2002 | US20020028764 Administering somatomedins |
| 03/07/2002 | US20020028763 Activity dependent neurotropic factor |
| 03/07/2002 | US20020028762 Medicament and method for treating renal disease |
| 03/07/2002 | US20020028515 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028508 Novel genes encoding proteins having prognostic, diagnostic, preventive , therapeutic and other uses |
| 03/07/2002 | US20020028494 57256 and 58289, novel human transporters and uses thereof |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |
| 03/07/2002 | US20020028485 Polypeptide; for use in diagnosis and treatment of cancer, lung, cardiovascular, inflammation, kidney, pain, psychological and nervous system disorders |
| 03/07/2002 | US20020028482 Nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of autoimune disease, arthritis, infections, myasthenia gravis, asthma and cancer |
| 03/07/2002 | US20020028469 Generating monoclonal antibodies |
| 03/07/2002 | US20020028449 26 Human secreted proteins |